The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with mosquito-borne malaria.

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally, and children are the most badly affected.

A new study has revealed alarming evidence of partial resistance to artemisinin, a crucial antimalarial drug, in Ugandan children with severe malaria. This resistance could hinder the effectiveness of current treatments,

A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children with severe forms of the parasitic disease.

Now, there's troubling news that the malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save these young lives. “This is the first study from Africa showing that children with malaria and clear signs of severe disease are experiencing at least partial resistance to artemisinin,